Optical imaging with a cathepsin B activated probe for the enhanced detection of esophageal adenocarcinoma by dual channel fluorescent upper GI endoscopy

Peiman Habibollahi, Jose Luiz Figueiredo, Pedram Heidari, Austin M. Dulak, Yu Imamura, Adam J. Bass, Shuji Ogino, Andrew T. Chan, Umar Mahmood

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Despite significant advances in diagnosis and treatment, the prognosis of esophageal adenocar-cinoma remains poor highlighting the importance of early detection. Although white light (WL) upper endoscopy can be used for screening of the esophagus, it has limited sensitivity for early stage disease. Thus, development of new imaging technology to improve the diagnostic capabilities of upper GI endoscopy for early detection of esophageal adenocarcinoma is an important unmet need. The goal of this study was to develop a method for the detection of malignant lesions in the esophagus using WL upper endoscopy combined with near infrared (NIR) imaging with a protease activatable probe (Prosense750) selective for cathepsin B (CTSB). An orthotopic murine model for distal esophageal adenocarcinoma was generated through the implantation of OE-33 and OE-19 human esophageal adenocarcinoma lines in immunocompromised mice. The mice were imaged simultaneously for WL and NIR signal using a custom-built dual channel upper GI endo-scope. The presence of tumor was confirmed by histology and target to background ratios (TBR) were compared for both WL and NIR imaging. NIR imaging with ProSense750 significantly im-proved upon the TBRs of esophageal tumor foci, with a TBR of 3.64±0.14 and 4.50±0.11 for the OE-33 and OE-19 tumors respectively, compared to 0.88±0.04 and 0.81±0.02 TBR for WL im-aging. The combination of protease probes with novel imaging devices has the potential to improve esophageal tumor detection by fluorescently highlighting neoplastic regions.

Original languageEnglish (US)
Pages (from-to)227-234
Number of pages8
JournalTheranostics
Volume2
Issue number2
DOIs
StatePublished - Apr 19 2012
Externally publishedYes

Fingerprint

Cathepsin B
Optical Imaging
Endoscopy
Adenocarcinoma
Light
Esophagus
Neoplasms
Peptide Hydrolases
Histology
Technology
Equipment and Supplies

Keywords

  • Cathepsin B
  • Esophageal adenocarcinoma
  • Near infrared imaging
  • Prosense750

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Cite this

Optical imaging with a cathepsin B activated probe for the enhanced detection of esophageal adenocarcinoma by dual channel fluorescent upper GI endoscopy. / Habibollahi, Peiman; Figueiredo, Jose Luiz; Heidari, Pedram; Dulak, Austin M.; Imamura, Yu; Bass, Adam J.; Ogino, Shuji; Chan, Andrew T.; Mahmood, Umar.

In: Theranostics, Vol. 2, No. 2, 19.04.2012, p. 227-234.

Research output: Contribution to journalArticle

Habibollahi, Peiman ; Figueiredo, Jose Luiz ; Heidari, Pedram ; Dulak, Austin M. ; Imamura, Yu ; Bass, Adam J. ; Ogino, Shuji ; Chan, Andrew T. ; Mahmood, Umar. / Optical imaging with a cathepsin B activated probe for the enhanced detection of esophageal adenocarcinoma by dual channel fluorescent upper GI endoscopy. In: Theranostics. 2012 ; Vol. 2, No. 2. pp. 227-234.
@article{a8055153c6cf4caf976b7618d741418f,
title = "Optical imaging with a cathepsin B activated probe for the enhanced detection of esophageal adenocarcinoma by dual channel fluorescent upper GI endoscopy",
abstract = "Despite significant advances in diagnosis and treatment, the prognosis of esophageal adenocar-cinoma remains poor highlighting the importance of early detection. Although white light (WL) upper endoscopy can be used for screening of the esophagus, it has limited sensitivity for early stage disease. Thus, development of new imaging technology to improve the diagnostic capabilities of upper GI endoscopy for early detection of esophageal adenocarcinoma is an important unmet need. The goal of this study was to develop a method for the detection of malignant lesions in the esophagus using WL upper endoscopy combined with near infrared (NIR) imaging with a protease activatable probe (Prosense750) selective for cathepsin B (CTSB). An orthotopic murine model for distal esophageal adenocarcinoma was generated through the implantation of OE-33 and OE-19 human esophageal adenocarcinoma lines in immunocompromised mice. The mice were imaged simultaneously for WL and NIR signal using a custom-built dual channel upper GI endo-scope. The presence of tumor was confirmed by histology and target to background ratios (TBR) were compared for both WL and NIR imaging. NIR imaging with ProSense750 significantly im-proved upon the TBRs of esophageal tumor foci, with a TBR of 3.64±0.14 and 4.50±0.11 for the OE-33 and OE-19 tumors respectively, compared to 0.88±0.04 and 0.81±0.02 TBR for WL im-aging. The combination of protease probes with novel imaging devices has the potential to improve esophageal tumor detection by fluorescently highlighting neoplastic regions.",
keywords = "Cathepsin B, Esophageal adenocarcinoma, Near infrared imaging, Prosense750",
author = "Peiman Habibollahi and Figueiredo, {Jose Luiz} and Pedram Heidari and Dulak, {Austin M.} and Yu Imamura and Bass, {Adam J.} and Shuji Ogino and Chan, {Andrew T.} and Umar Mahmood",
year = "2012",
month = "4",
day = "19",
doi = "10.7150/thno.4088",
language = "English (US)",
volume = "2",
pages = "227--234",
journal = "Theranostics",
issn = "1838-7640",
publisher = "Ivyspring International Publisher",
number = "2",

}

TY - JOUR

T1 - Optical imaging with a cathepsin B activated probe for the enhanced detection of esophageal adenocarcinoma by dual channel fluorescent upper GI endoscopy

AU - Habibollahi, Peiman

AU - Figueiredo, Jose Luiz

AU - Heidari, Pedram

AU - Dulak, Austin M.

AU - Imamura, Yu

AU - Bass, Adam J.

AU - Ogino, Shuji

AU - Chan, Andrew T.

AU - Mahmood, Umar

PY - 2012/4/19

Y1 - 2012/4/19

N2 - Despite significant advances in diagnosis and treatment, the prognosis of esophageal adenocar-cinoma remains poor highlighting the importance of early detection. Although white light (WL) upper endoscopy can be used for screening of the esophagus, it has limited sensitivity for early stage disease. Thus, development of new imaging technology to improve the diagnostic capabilities of upper GI endoscopy for early detection of esophageal adenocarcinoma is an important unmet need. The goal of this study was to develop a method for the detection of malignant lesions in the esophagus using WL upper endoscopy combined with near infrared (NIR) imaging with a protease activatable probe (Prosense750) selective for cathepsin B (CTSB). An orthotopic murine model for distal esophageal adenocarcinoma was generated through the implantation of OE-33 and OE-19 human esophageal adenocarcinoma lines in immunocompromised mice. The mice were imaged simultaneously for WL and NIR signal using a custom-built dual channel upper GI endo-scope. The presence of tumor was confirmed by histology and target to background ratios (TBR) were compared for both WL and NIR imaging. NIR imaging with ProSense750 significantly im-proved upon the TBRs of esophageal tumor foci, with a TBR of 3.64±0.14 and 4.50±0.11 for the OE-33 and OE-19 tumors respectively, compared to 0.88±0.04 and 0.81±0.02 TBR for WL im-aging. The combination of protease probes with novel imaging devices has the potential to improve esophageal tumor detection by fluorescently highlighting neoplastic regions.

AB - Despite significant advances in diagnosis and treatment, the prognosis of esophageal adenocar-cinoma remains poor highlighting the importance of early detection. Although white light (WL) upper endoscopy can be used for screening of the esophagus, it has limited sensitivity for early stage disease. Thus, development of new imaging technology to improve the diagnostic capabilities of upper GI endoscopy for early detection of esophageal adenocarcinoma is an important unmet need. The goal of this study was to develop a method for the detection of malignant lesions in the esophagus using WL upper endoscopy combined with near infrared (NIR) imaging with a protease activatable probe (Prosense750) selective for cathepsin B (CTSB). An orthotopic murine model for distal esophageal adenocarcinoma was generated through the implantation of OE-33 and OE-19 human esophageal adenocarcinoma lines in immunocompromised mice. The mice were imaged simultaneously for WL and NIR signal using a custom-built dual channel upper GI endo-scope. The presence of tumor was confirmed by histology and target to background ratios (TBR) were compared for both WL and NIR imaging. NIR imaging with ProSense750 significantly im-proved upon the TBRs of esophageal tumor foci, with a TBR of 3.64±0.14 and 4.50±0.11 for the OE-33 and OE-19 tumors respectively, compared to 0.88±0.04 and 0.81±0.02 TBR for WL im-aging. The combination of protease probes with novel imaging devices has the potential to improve esophageal tumor detection by fluorescently highlighting neoplastic regions.

KW - Cathepsin B

KW - Esophageal adenocarcinoma

KW - Near infrared imaging

KW - Prosense750

UR - http://www.scopus.com/inward/record.url?scp=84864532128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864532128&partnerID=8YFLogxK

U2 - 10.7150/thno.4088

DO - 10.7150/thno.4088

M3 - Article

C2 - 22400064

AN - SCOPUS:84864532128

VL - 2

SP - 227

EP - 234

JO - Theranostics

JF - Theranostics

SN - 1838-7640

IS - 2

ER -